in Situ Breast Cancer
Showing 1 - 25 of >10,000
Breast Cancer, Invasive Breast Cancer, in Situ Breast Cancer Trial in Boston (Standard Genetic Counseling, Quantitative Genetic
Recruiting
- Breast Cancer
- +3 more
- Standard Genetic Counseling
- Quantitative Genetic Counseling
-
Boston, MassachusettsDana Farber Cancer Institute
Sep 26, 2022
Breast Cancer, Breast Carcinoma in Situ, Breast Cancer Female Trial (Control Arm ACSM Guidelines, Experimental Arm 6-12-25
Not yet recruiting
- Breast Cancer
- +2 more
- Control Arm ACSM Guidelines
- Experimental Arm 6-12-25 repetitions per set
- (no location specified)
Nov 6, 2023
Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,
Not yet recruiting
- Breast Atypical Hyperplasia
- +3 more
- Acolbifene Hydrochloride
- +4 more
-
Duarte, California
- +3 more
Jul 11, 2023
After Oncoplastic Breast Conserving Surgery
Not yet recruiting
- Breast Cancer Stage I
- +2 more
- Breast-conserving surgery
- (no location specified)
Feb 2, 2023
Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Ductal Carcinoma In Situ Trial in Houston
Completed
- Breast Atypical Ductal Hyperplasia
- +4 more
- Bexarotene
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2022
Standard Breast Cancer Risk Assessment for African American and
Not yet recruiting
- Breast Atypical Ductal Hyperplasia
- +3 more
- Biospecimen Collection
- +2 more
-
Jacksonville, FloridaMayo Clinic in Florida
Feb 22, 2023
Breast Cancer Trial in Rozzano (external beams radiotherapy, brachytherapy)
Recruiting
- Breast Cancer
- external beams radiotherapy
- brachytherapy
-
Rozzano, Milano, ItalyIRCCS Istituto Clinico Humanitas
Jan 13, 2023
Breast Cancer, Node-positive Breast Cancer, Breast Adenocarcinoma Trial in Richmond, South Hill (External Beam Radiation
Active, not recruiting
- Breast Cancer
- +4 more
- External Beam Radiation Therapy
- +2 more
-
Richmond, Virginia
- +1 more
Dec 16, 2022
BRCA Mutation, PALB2 Gene Mutation, Ductal Carcinoma in Situ Trial in Italy (drug, other, behavioral)
Not yet recruiting
- BRCA Mutation
- +3 more
- Tamoxifen 10 Mg Tablet
- +2 more
-
Genoa, Italy
- +3 more
Sep 11, 2023
Breast Cancer - Ductal Carcinoma in Situ (DCIS), Breast-Conserving Surgery Trial (Histolog Scanner)
Not yet recruiting
- Breast Cancer - Ductal Carcinoma in Situ (DCIS)
- Breast-Conserving Surgery
- Histolog Scanner
- (no location specified)
Jul 6, 2023
Anatomic Stage 0 Breast Cancer AJCC v8, Bilateral Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in Chicago
Recruiting
- Anatomic Stage 0 Breast Cancer AJCC v8
- +5 more
- Intraoperative Imaging
- Lumpectomy
-
Chicago, Illinois
- +3 more
Nov 30, 2022
Breast Cancer, Carcinoma in Situ Trial in Kannur (Triage of clinical breast examination positive women using handheld ultrasound
Recruiting
- Breast Cancer
- Carcinoma in Situ
- Triage of clinical breast examination positive women using handheld ultrasound by non-radiologists.
-
Kannur, IndiaMalabar Cancer Care Society Kannur
Sep 28, 2023
MRI Characterization of Mammographically Detected DCIS
Recruiting
- Breast Cancer, Stage 0
- Breast MRI
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 21, 2022
Ductal Breast Carcinoma in Situ, Invasive Breast Cancer, Early-stage Breast Cancer Trial in Mérida (Hypofractionated
Recruiting
- Ductal Breast Carcinoma in Situ
- +6 more
- Hypofractionated radiotherapy
-
Mérida, Yucatán, MexicoUnidad Medica de Alta Especialidad
Nov 7, 2022
Atypical Hyperplasia, Lobular Carcinoma in Situ Trial in Rochester (Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 2 mg/each
Recruiting
- Atypical Hyperplasia
- Lobular Carcinoma in Situ
- Tamoxifen
- +2 more
-
Evanston, Illinois
- +1 more
Jan 20, 2023
Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)
Recruiting
- Anatomic Stage 0 Breast Cancer AJCC v8
- +4 more
- Non-Interventional Study
-
Jacksonville, FloridaMayo Clinic in Florida
Oct 24, 2023
Breast Cancer, Ductal Carcinoma in Situ Trial in Basking Ridge, Commack, New York (MRI)
Active, not recruiting
- Breast Cancer
- Ductal Carcinoma in Situ
- MRI
-
Basking Ridge, New Jersey
- +2 more
Nov 7, 2022
Survival Rate of HER2-Low Breast Cancer Patients
Completed
- HER2 Low Breast Carcinoma
- immunohistochemistry (IHC) and in situ hybridization (ISH) Test
- (no location specified)
Mar 2, 2023
Ductal Carcinoma in Situ Trial in Durham (Decision Support Tool with Active Monitoring, Decision Support Tool without Active
Completed
- Ductal Carcinoma in Situ
- Decision Support Tool with Active Monitoring
- Decision Support Tool without Active Monitoring
-
Durham, North CarolinaDuke Mammography Clinic
Jan 4, 2023
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma
Not yet recruiting
- Anatomic Stage 0 Breast Cancer AJCC v8
- +3 more
- Accelerated Partial Breast Irradiation
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 18, 2023
Early-stage Breast Cancer, Breast Carcinoma in Situ, Breast Tumors Trial in Santa Monica (Intraoperative Radiation Therapy
Recruiting
- Early-stage Breast Cancer
- +2 more
- Intraoperative Radiation Therapy (IORT)
-
Santa Monica, CaliforniaJohn Wayne Cancer Institute, Providence Saint John's Health Cent
Mar 18, 2022
Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Ductal Breast Carcinoma In Situ Trial in Houston (Behavioral,
Active, not recruiting
- Deleterious BRCA1 Gene Mutation
- +5 more
- Behavioral, Psychological or Informational Intervention
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Triple Negative Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III Trial in Boston (Implantable Microdevice (IMD))
Not yet recruiting
- Triple Negative Breast Cancer
- +6 more
- Implantable Microdevice (IMD)
-
Boston, Massachusetts
- +1 more
Mar 8, 2023
Metastatic NSCLC, Metastatic Triple-negative Breast Cancer Trial in Houston (biological, drug, radiation)
Active, not recruiting
- Metastatic Non-small Cell Lung Cancer
- Metastatic Triple-negative Breast Cancer
- ADV/HSV-tk
- +3 more
-
Houston, TexasHouston Methodist Cancer Center
Dec 28, 2022